Fibromyalgia (FM) is a medical condition that causes widespread pain alongside fatigue, sleep problems, and difficulty thinking, often called “fibro fog.” However, it is still widely debated as to the cause of fibromyalgia. The debate centers around whether fibromyalgia is linked to autoimmune disorders, where the body’s immune system attacks its own tissues. The general consensus seems to be swaying in favor of fibromyalgia being an autoimmune disease.
Explaining Autoimmunity
Autoimmunity is a condition that describes an immune response in which the immune system attacks healthy tissue and organs in the body. This attack causes cell and tissue damage, inflammation, and even diseases. It happens when the body’s immune system mistakenly deems healthy tissue or cells a threat and begins an assault on them.
There are organ-specific autoimmune diseases and systemic autoimmune diseases. Organ-specific autoimmune diseases include type 1 diabetes, multiple sclerosis, and thyroid disorders. Systemic autoimmune diseases cause a myriad of different issues, including lupus, rheumatoid arthritis, and inflammatory bowel disease, to name a few. Autoimmune diseases present with varied symptoms depending on which organs experience dysfunction or damage. Fatigue often burdens individuals struggling with these complex and challenging conditions.
Unexplained weight fluctuations frequently disrupt the lives of those battling autoimmune disorders. Dizziness can significantly impair balance and overall well-being for affected people. Difficulty focusing hinders concentration and impacts daily tasks for many patients. Muscle pain and joint swelling commonly restrict movement and cause considerable discomfort.
What Suggests a Link?
Some research suggests fibromyalgia might involve problems with the immune system. While evidence suggests its link to neuroinflammation, the hypothesis is not getting much acceptance from the medical community. Fibromyalgia’s existence was contested for many years, fortunately being recognised as a disease, with doctors who believed in its existence classifying it as “arthritis-like”.
Early research initially suggested fibromyalgia might be an autoimmune condition due to similarities with diseases like lupus, multiple sclerosis, and rheumatoid arthritis. However, this early work failed to reveal expected hallmarks of autoimmunity, such as inflammation, autoantibodies, or organ damage from immune system attacks. Newer research now leads experts to consider fibromyalgia a neurological or neuroimmune pain condition, and emerging evidence suggests it may indeed possess the characteristics previously absent, prompting a re-evaluation of its underlying mechanisms.
In more recent research, scientists have found certain autoantibodies, antibodies that mistakenly target the body’s own cells, in some patients with fibromyalgia. Researchers found unusually high levels of several autoantibodies, including those for serotonin, phospholipids, gangliosides, and thyroid glands. It’s noteworthy to mention that not every patient with fibromyalgia exhibited these autoantibodies, but rates ranged from roughly 19% to 73%.
Researchers conducted experiments on mice, transferring blood from individuals with fibromyalgia into them. The results showed that this transfer appeared to trigger fibromyalgia-like symptoms in the mice. These symptoms included a developed hypersensitivity to pain and cold, losing nerve fibers in the skin, becoming fatigued and less active, and losing grip strength. Some researchers believe that removing or neutralizing these autoantibodies could be a potential treatment approach for certain fibromyalgia patients.
Why Many Experts Don’t Consider Fibromyalgia an Autoimmune Disease
Despite these findings, most rheumatologists (doctors specializing in joint diseases) do not classify fibromyalgia as an autoimmune disease. Early research focused on finding signs of inflammation and other hallmarks of autoimmune disorders, but consistently found normal results. This led to a shift in understanding where fibromyalgia was seen as a disorder of how the brain and nervous system process pain, rather than primarily an inflammatory condition.
This perspective emphasizes noci-plastic pain, which means pain arises from changes within the central nervous system (brain and spinal cord) that amplify sensory signals. People with fibromyalgia often experience increased pain sensitivity even to non-painful stimuli like light touch or sound. Brain scans reveal altered patterns of brain activity related to pain processing.
Fibromyalgia also frequently occurs alongside other chronic pain conditions like headaches, irritable bowel syndrome (IBS), and tension headaches. This suggests a shared underlying mechanism involving the nervous system’s response to pain.
A Complex Picture
The truth is likely more complicated than a simple “yes” or “no” answer. While fibromyalgia doesn’t fit the classic definition of an autoimmune disease, it does involve immune system components in some individuals. It’s possible that certain subgroups of people with fibromyalgia have underlying immune abnormalities that contribute to their symptoms.
What Does This Mean for Treatment?
Currently, fibromyalgia remains a diagnosis of exclusion, so new research validating the findings of autoimmunity would represent a significant advancement and lead toward diagnostic tests. A 2022 study focused on identifying biomarkers for diagnosing and managing fibromyalgia; researchers found that participants with fibromyalgia had high levels of 19 inflammatory serum proteins, indicating widespread inflammation.
Many immunosuppressive drugs already exist for other autoimmune diseases, potentially allowing clinicians to explore off-label use immediately. However, scientists still need to determine whether these existing immunosuppressants are safe and effective specifically for FM patients.
Understanding the complex nature of fibromyalgia remains important for developing effective treatments. Current approaches primarily focus on symptom management through medication, exercise, and psychological therapies. Confirming a significant autoimmune component in some FM patients could unlock new avenues for targeted treatments that directly address underlying immune dysfunction.
The Ongoing Search for Answers
The question of whether fibromyalgia is an autoimmune disease remains unanswered definitively. While evidence suggests involvement of the immune system in certain individuals with fibromyalgia, it does not fully tick off the criteria for a classic autoimmune disorder. Ongoing research continues to explore the complex interplay between the immune system, nervous system, and gut microbiome in fibromyalgia, paving the way for more effective treatments and a deeper understanding of this challenging condition.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
Read More: Fibromyalgia Linked To Nearly 20 Different Kinds Of Gut Bacteria